186 related articles for article (PubMed ID: 36970193)
1. G protein-coupled receptor 35 attenuates nonalcoholic steatohepatitis by reprogramming cholesterol homeostasis in hepatocytes.
Wei X; Yin F; Wu M; Xie Q; Zhao X; Zhu C; Xie R; Chen C; Liu M; Wang X; Ren R; Kang G; Zhu C; Cong J; Wang H; Wang X
Acta Pharm Sin B; 2023 Mar; 13(3):1128-1144. PubMed ID: 36970193
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice).
Xu Y; Zhu Y; Hu S; Xu Y; Stroup D; Pan X; Bawa FC; Chen S; Gopoju R; Yin L; Zhang Y
Hepatology; 2021 Jun; 73(6):2251-2265. PubMed ID: 33098092
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte-specific expression of human carboxylesterase 2 attenuates nonalcoholic steatohepatitis in mice.
Xu Y; Pan X; Hu S; Zhu Y; Cassim Bawa F; Li Y; Yin L; Zhang Y
Am J Physiol Gastrointest Liver Physiol; 2021 Jan; 320(2):G166-G174. PubMed ID: 33325808
[TBL] [Abstract][Full Text] [Related]
4. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
[TBL] [Abstract][Full Text] [Related]
5. Lipocalin-2 Protects Against Diet-Induced Nonalcoholic Fatty Liver Disease by Targeting Hepatocytes.
Xu Y; Zhu Y; Jadhav K; Li Y; Sun H; Yin L; Kasumov T; Chen X; Zhang Y
Hepatol Commun; 2019 Jun; 3(6):763-775. PubMed ID: 31168511
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte-Specific Loss of PPARγ Protects Mice From NASH and Increases the Therapeutic Effects of Rosiglitazone in the Liver.
Lee SM; Pusec CM; Norris GH; De Jesus A; Diaz-Ruiz A; Muratalla J; Sarmento-Cabral A; Guzman G; Layden BT; Cordoba-Chacon J
Cell Mol Gastroenterol Hepatol; 2021; 11(5):1291-1311. PubMed ID: 33444819
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease.
Xu Y; Zhu Y; Hu S; Pan X; Bawa FC; Wang HH; Wang DQ; Yin L; Zhang Y
Mol Metab; 2021 Sep; 51():101244. PubMed ID: 33930596
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis.
Li T; Matozel M; Boehme S; Kong B; Nilsson LM; Guo G; Ellis E; Chiang JY
Hepatology; 2011 Mar; 53(3):996-1006. PubMed ID: 21319191
[TBL] [Abstract][Full Text] [Related]
9. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters.
Sun L; Pang Y; Wang X; Wu Q; Liu H; Liu B; Liu G; Ye M; Kong W; Jiang C
Acta Pharm Sin B; 2019 Jul; 9(4):702-710. PubMed ID: 31384531
[TBL] [Abstract][Full Text] [Related]
10. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of lodoxamide on hepatic steatosis through GPR35.
Nam SY; Park SJ; Im DS
Cell Signal; 2019 Jan; 53():190-200. PubMed ID: 30304698
[TBL] [Abstract][Full Text] [Related]
12. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
[TBL] [Abstract][Full Text] [Related]
13. Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis.
Van Rooyen DM; Larter CZ; Haigh WG; Yeh MM; Ioannou G; Kuver R; Lee SP; Teoh NC; Farrell GC
Gastroenterology; 2011 Oct; 141(4):1393-403, 1403.e1-5. PubMed ID: 21703998
[TBL] [Abstract][Full Text] [Related]
14. Soyasaponin A
Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L
Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448
[TBL] [Abstract][Full Text] [Related]
15. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
16. A new mechanism of thyroid hormone receptor β agonists ameliorating nonalcoholic steatohepatitis by inhibiting intestinal lipid absorption via remodeling bile acid profiles.
Sun K; Zhu NL; Huang SL; Qu H; Gu YP; Qin L; Liu J; Leng Y
Acta Pharmacol Sin; 2024 May; ():. PubMed ID: 38789494
[TBL] [Abstract][Full Text] [Related]
17. Squalene Epoxidase Induces Nonalcoholic Steatohepatitis Via Binding to Carbonic Anhydrase III and is a Therapeutic Target.
Liu D; Wong CC; Zhou Y; Li C; Chen H; Ji F; Go MYY; Wang F; Su H; Wei H; Cai Z; Wong N; Wong VWS; Yu J
Gastroenterology; 2021 Jun; 160(7):2467-2482.e3. PubMed ID: 33647280
[TBL] [Abstract][Full Text] [Related]
18. IRE1A Stimulates Hepatocyte-Derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis.
Dasgupta D; Nakao Y; Mauer AS; Thompson JM; Sehrawat TS; Liao CY; Krishnan A; Lucien F; Guo Q; Liu M; Xue F; Fukushima M; Katsumi T; Bansal A; Pandey MK; Maiers JL; DeGrado T; Ibrahim SH; Revzin A; Pavelko KD; Barry MA; Kaufman RJ; Malhi H
Gastroenterology; 2020 Oct; 159(4):1487-1503.e17. PubMed ID: 32574624
[TBL] [Abstract][Full Text] [Related]
19. Role of Cholesterol-Associated Steatohepatitis in the Development of NASH.
Horn CL; Morales AL; Savard C; Farrell GC; Ioannou GN
Hepatol Commun; 2022 Jan; 6(1):12-35. PubMed ID: 34558856
[TBL] [Abstract][Full Text] [Related]
20. G Protein-Coupled Receptor GPR35 Suppresses Lipid Accumulation in Hepatocytes.
Lin LC; Quon T; Engberg S; Mackenzie AE; Tobin AB; Milligan G
ACS Pharmacol Transl Sci; 2021 Dec; 4(6):1835-1848. PubMed ID: 34927014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
